- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.99%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 13 February, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | -3.77% | -0.99% | 1.84% | -2.98% | -7.24% | -2.94% | 18.26% | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | -0.83% | -1.01% | 1.51% | -0.86% | -3.72% | 2.74% | 24.22% | 15.63% | 20.13% | 12.21% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -1.99% | -0.96% | -0.18% | -0.98% | -1.26% | 9.59% | 13.98% | 11.45% | 13.78% | 14.08% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -1.53% | -1.22% | -0.36% | 1.68% | -1.55% | 7.95% | 21.49% | 20.31% | 20.33% | 17.55% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.46% | -1.19% | 1.41% | 5.72% | 5.88% | 28.78% | 33.68% | 28.49% | 22.21% | 16.99% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -3.56% | -1.06% | 0.58% | -1.64% | -4.97% | 0.24% | 12.71% | 15.45% | 14.98% | 15.62% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -8.89% | 32.42% | 41.76% | -10.78% |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 3.3% | 0.02% | 3.21% | 2.32% | -1.92% | -1.63% | 2.13% | -1.19% | -2.59% | -6.96% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | -8.02% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 98.31% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 1.69% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.96% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.97% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.35% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.71% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.51% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 4.43% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 3.98% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.70% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 3.62% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.07% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.04% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.95% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.82% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 2.57% |
| Wockhardt Limited | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 2.27% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.20% |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.77% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.73% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 1.69% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.53% |
| FDC Limited | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.40% |
| Sumitomo Chemical India Limited | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.35% |
| SBI Life Insurance Company Limited | SBILIFE (INE123W01016) | Insurance | 1.25% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.23% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.22% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.21% |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 1.19% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.19% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 1.13% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.13% |
| Standard Glass Lining Technology Ltd | SGLTL (INE0M4D01010) | Industrial Manufacturing | 1.05% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.99% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.93% |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.86% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.85% |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 0.81% |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.75% |
| UPL Limited | UPL (INE628A01036) | Fertilizers & Agrochemicals | 0.72% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.70% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.48% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 October, 2025
NAV history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV |
|---|---|
| 13 February, 2026 | 15.0528 |
| 12 February, 2026 | 15.2036 |
| 11 February, 2026 | 15.2726 |
| 10 February, 2026 | 15.0687 |
| 9 February, 2026 | 15.0231 |
| 6 February, 2026 | 14.7802 |
| 5 February, 2026 | 14.8743 |
| 4 February, 2026 | 14.9225 |
| 3 February, 2026 | 14.9558 |
| 2 February, 2026 | 14.5531 |
| 30 January, 2026 | 14.6772 |
| 29 January, 2026 | 14.4974 |
| 28 January, 2026 | 14.6527 |
| 27 January, 2026 | 14.6290 |
| 23 January, 2026 | 14.7041 |
| 22 January, 2026 | 14.8855 |
| 21 January, 2026 | 14.7300 |
| 20 January, 2026 | 14.8515 |
| 19 January, 2026 | 15.2072 |
| 16 January, 2026 | 15.3278 |
| 14 January, 2026 | 15.4770 |
| 13 January, 2026 | 15.5144 |
| 12 January, 2026 | 15.5243 |
| 9 January, 2026 | 15.6293 |
| 8 January, 2026 | 15.8106 |
| 7 January, 2026 | 16.0298 |
| 6 January, 2026 | 15.9222 |
| 5 January, 2026 | 15.7074 |
| 2 January, 2026 | 15.7570 |
| 1 January, 2026 | 15.6426 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 15.0528 as on 13 February, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -3.77% as on 13 February, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -2.94% as on 13 February, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 18.26% as on 13 February, 2026.